Paradigm Peptide vs Peptide Technologies
Independent side-by-side comparison across the 0 peptides both vendors sell. Composite scores, lab quality, and verified pricing.
Paradigm Peptide
Top Retatrutide vendor by score (9.0 across 14 tests). Strong on metabolic peptides.
Paradigm Peptide full review →Peptide Technologies
5 BPC-157 tests with score variance 5.0–10.0. GHK-Cu and Ipamorelin coverage solid.
Peptide Technologies full review →Side-by-side breakdown
| PEPTIDE | PARADIGM PEPTIDE | PEPTIDE TECHNOLOGIES | WINNER |
|---|---|---|---|
| Ipamorelin |
9.0
A (6 tests)
|
—(not sold)
|
Paradigm Peptide only |
| Tirzepatide |
8.4
B+ (14 tests)
|
—(not sold)
|
Paradigm Peptide only |
| Retatrutide |
7.0
B (14 tests)
|
—(not sold)
|
Paradigm Peptide only |
| GHK-Cu |
—(not sold)
|
7.4
B (6 tests)
|
Peptide Technologies only |
| BPC-157 |
—(not sold)
|
6.5
B (5 tests)
|
Peptide Technologies only |
Which to choose
Across the 0 peptides both vendors sell, Paradigm Peptide scores higher on 0, Peptide Technologies scores higher on 0, and 0 are within 0.3 points (effectively tied). Peptide Technologies additionally sells GHK-Cu, BPC-157; Paradigm Peptide does not. Paradigm Peptide additionally sells Ipamorelin, Tirzepatide, Retatrutide; Peptide Technologies does not.
Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.
Full profiles: Paradigm Peptide review · Peptide Technologies review